
By Joe Edwards
Reporter
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
Researchers have made a breakthrough that could represent a major step forward in making the male "pill" a reality.
The Baylor College of Medicine's Center for Drug Discovery's research focused on a compound that can inhibit a particular protein crucial for fertility in males. The compound can target the protein, thus impeding sperm mobility, the researchers said.
Read more: Compare Top Health Savings Accounts
Read More
Listen to Women—Birth Control’s Side Effects Are Real | Opinion5 min read

Woman Misdiagnosed for Years Before Discovering Source of Severe Pain9 min read

The effects of the compound are temporary, allowing normal sperm function to return after the compound has exited the system.
"Although researchers have been investigating several strategies to develop male contraceptives, we still do not have a birth control pill for men," said Dr Martin Matzuk, director of the Center for Drug Discovery.

...
"In this study we focused on a novel approach – identifying a small molecule that would inhibit serine/threonine kinase 33 (STK33), a protein that is specifically required for fertility in both men and mice.
Read more: What Is a Health Savings Account?
"STK33 is therefore considered a viable target with minimal safety concerns for contraception in men," he added.
The compound has only been tested on mice so far, as other compounds are still to be tested and further work must be done before human trials can commence.
"The next steps to pursue would be testing the CDD-2807 compound on non-human primates to see if the same contraceptive effects are observed," Courtney Sutton, a postdoctoral associate at Baylor College of Medicine's Center for Drug Discovery told Newsweek.
The female contraceptive pill, commonly known as "the pill," was approved by the U.S. Food and Drug Administration (FDA) on May 9, 1960. The pill revolutionized reproductive health by providing women with an effective and convenient method of birth control.
Despite early formulations causing side effects such as nausea and weight gain due to high hormone levels, Planned Parenthood says later versions of the pill reduced these issues by lowering the hormone dosage.
Although the female contraceptive pill is now generally safer and widely available, some women still experience harmful side effects.
Research into a male contraceptive pill has been advancing significantly in recent years. Efforts to create an effective and safe male contraceptive have faced numerous challenges, primarily due to the high sperm production rate in men and the need to ensure any contraceptive method is easily reversible and has minimal side effects.
"Research into male contraception has been going on for years and will still continue to be researched for many years in the future, however challenges with finding suitable non-hormonal targets that will prevent sperm motility and/or sperm morphology and not have adverse effects on weight and testis size make the path to obtaining reliable reversible contraception just a little longer to traverse," said Sutton.
In 2022 a hormone-free male contraceptive pill began clinical trials in the U.K.
This drug works by inhibiting the retinoic acid receptor-alpha (RAR-alpha), a pathway crucial for sperm production. Preclinical studies demonstrated that the drug was 99% effective in preventing pregnancies in mice and fully reversible, showing no apparent side effects.
Medical experts have previously speculated that the 2022 overturn of Roe v. Wade could accelerate research and development for a male birth control pill.
Currently, the main contraceptive methods readily available to men are condoms, vasectomies or spermicides, chemical substances that kills sperm.
Do you have a story we should be covering? Do you have any questions about reproductive health? Contact LiveNews@newsweek.com
View 0 Comments
Submit Correction
View Editorial & AI Guidelines